Effective date: March 13, 2019
RenalSense Ltd. (“us”, “we”, or “our”) operates the www.renalsense.com website (hereinafter referred to as the “Service”).
This page informs you of our policies regarding the collection, use and disclosure of personal data when you use our Service and the choices you have associated with that data.
We use your data to provide and improve the Service. By using the Service, you agree to the collection and use of information in accordance with this policy. Unless otherwise defined in this Privacy and Cookie Policy, the terms used in this Privacy and Cookie Policy have the same meanings as in our Terms and Conditions, accessible from www.renalsense.com.
Service
Service is the www.renalsense.com website operated by RenalSense Ltd.
Personal Data
Personal Data means data about a living individual who can be identified from those data (or from those and other information either in our possession or likely to come into our possession).
Usage Data
Usage Data is data collected automatically either generated by the use of the Service or from the Service infrastructure itself (for example, the duration of a page visit).
Cookies
Cookies are small files stored on your device (computer or mobile device).
Data Controller
Data Controller means the natural or legal person who (either alone or jointly or in common with other persons) determines the purposes for which and the manner in which any personal information are, or are to be, processed.
For the purpose of this Privacy and Cookie Policy, we are a Data Controller of your Personal Data.
Data Processors (or Service Providers)
Data Processor (or Service Provider) means any natural or legal person who processes the data on behalf of the Data Controller.
We may use the services of various Service Providers in order to process your data more effectively.
Data Subject (or User)
Data Subject is any living individual who is using our Service and is the subject of Personal Data.
We collect several different types of information for various purposes to provide and improve our Service to you.
Personal Data
While using our Service, we may ask you to provide us with certain personally identifiable information that can be used to contact or identify you (“Personal Data”). Personally identifiable information may include, but is not limited to:
We may use your Personal Data to contact you with newsletters, marketing or promotional materials and other information that may be of interest to you. You may opt out of receiving any, or all, of these communications from us by following the unsubscribe link or the instructions provided in any email we send.
Usage Data
We may also collect information on how the Service is accessed and used (“Usage Data”). This Usage Data may include information such as your computer’s Internet Protocol address (e.g. IP address), browser type, browser version, the pages of our Service that you visit, the time and date of your visit, the time spent on those pages, unique device identifiers and other diagnostic data.
Location Data
We may use and store information about your location if you give us permission to do so (“Location Data”). We use this data to provide features of our Service, to improve and customize our Service.
You can enable or disable location services when you use our Service at any time by way of your device settings.
RenalSense Ltd. uses the collected data for various purposes:
Cookies are small data files that are stored on an Internet user’s computer by a web server. Cookies contain user information such as login ID and allow us to recognize your browser preferences. Cookies help us to deliver certain functionalities to you and to guarantee the best user experience possible.
When you visit our Websites, we may use cookies and similar technologies for the following purposes:
We also use 3rd party remarketing cookies, Google Analytics cookies. To see an overview of privacy at Google and how this applies to Google Analytics, visit https://www.google.com/policies/privacy/. You may opt out of tracking by Google Analytics by installing the Google Analytics opt-out browser add-on at https://tools.google.com/dlpage/gaoptout. The add-on prevents the Google Analytics JavaScript (ga.js, analytics.js and dc.js) from sharing information with Google Analytics about visits activity.
Similarly, you can opt out of Google’s use of cookies by visiting Google’s Ads Settings. You can use your browser settings to withdraw your consent to our use of cookies at any time and delete cookies that have already been set.
The website www.allaboutcookies.org contains comprehensive information about the process of opting out on different browsers.
Note that by disabling certain categories of cookies you may be prevented from accessing some features of our website, or certain content or functionality may not be available.
If you are from the European Economic Area (EEA), RenalSense Ltd.’s legal basis for collecting and using the personal information described in this Privacy and Cookie Policy depends on the Personal Data we collect and the specific context in which we collect it.
RenalSense Ltd. may process your Personal Data because:
RenalSense Ltd. will retain your Personal Data only for as long as is necessary for the purposes set out in this Privacy and Cookie Policy. We will retain and use your Personal Data to the extent necessary to comply with our legal obligations (for example, if we are required to retain your data to comply with applicable laws), resolve disputes and enforce our legal agreements and policies.
RenalSense Ltd. will also retain Usage Data for internal analysis purposes. Usage Data is generally retained for a shorter period of time, except when this data is used to strengthen the security or to improve the functionality of our Service, or we are legally obligated to retain this data for longer periods.
Your information, including Personal Data, may be transferred to — and maintained on — computers located outside of your state, province, country or other governmental jurisdiction where the data protection laws may differ from those of your jurisdiction.
If you are located outside Israel and choose to provide information to us, please note that we transfer the data, including Personal Data, to Israel and process it there.
Your consent to this Privacy and Cookie Policy followed by your submission of such information represents your agreement to that transfer.
RenalSense Ltd. will take all the steps reasonably necessary to ensure that your data is treated securely and in accordance with this Privacy and Cookie Policy and no transfer of your Personal Data will take place to an organization or a country unless there are adequate controls in place including the security of your data and other personal information.
If RenalSense Ltd. is involved in a merger, acquisition or asset sale, your Personal Data may be transferred. We will provide notice before your Personal Data is transferred and becomes subject to a different Privacy and Cookie Policy.
Under certain circumstances, RenalSense Ltd. may be required to disclose your Personal Data if required to do so by law or in response to valid requests by public authorities (e.g. a court or a government agency).
RenalSense Ltd. may disclose your Personal Data in the good faith belief that such action is necessary to:
The security of your data is important to us but remember that no method of transmission over the Internet or method of electronic storage is 100% secure. While we strive to use commercially acceptable means to protect your Personal Data, we cannot guarantee its absolute security.
Our Policy on “Do Not Track” Signals under the California Online Protection Act (CalOPPA)
We do not support Do Not Track (“DNT”). Do Not Track is a preference you can set in your web browser to inform websites that you do not want to be tracked.
You can enable or disable Do Not Track by visiting the Preferences or Settings page of your web browser.
If you are a resident of the European Economic Area (EEA), you have certain data protection rights. RenalSense Ltd. aims to take reasonable steps to allow you to correct, amend, delete or limit the use of your Personal Data.
If you wish to be informed about what Personal Data we hold about you and if you want it to be removed from our systems, please contact us.
In certain circumstances, you have the following data protection rights:
The right to access, update or delete the information we have on you. Whenever made possible, you can access, update or request deletion of your Personal Data directly within your account settings section. If you are unable to perform these actions yourself, please contact us to assist you.
The right of rectification. You have the right to have your information rectified if that information is inaccurate or incomplete.
The right to object. You have the right to object to our processing of your Personal Data.
The right of restriction. You have the right to request that we restrict the processing of your personal information.
The right to data portability. You have the right to be provided with a copy of the information we have on you in a structured, machine-readable and commonly used format.
The right to withdraw consent. You also have the right to withdraw your consent at any time where RenalSense Ltd. relied on your consent to process your personal information.
Please note that we may ask you to verify your identity before responding to such requests.
You have the right to complain to a Data Protection Authority about our collection and use of your Personal Data. For more information, please contact your local data protection authority in the European Economic Area (EEA).
We may employ third party companies and individuals to facilitate our Service (“Service Providers”), provide the Service on our behalf, perform Service-related services or assist us in analyzing how our Service is used.
These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.
We may use third-party Service Providers to monitor and analyze the use of our Service.
Google Analytics
Google Analytics is a web analytics service offered by Google that tracks and reports website traffic. Google uses the data collected to track and monitor the use of our Service. This data is shared with other Google services. Google may use the collected data to contextualize and personalize the ads of its own advertising network. For more information on Google Analytics and opting-out, see “Cookie Policy” above.
For more information on the privacy practices of Google, please visit the Google Privacy & Terms web page: https://policies.google.com/privacy?hl=en.
Our Service may contain links to other sites that are not operated by us. If you click a third party link, you will be directed to that third party’s site. We strongly advise you to review the Privacy and Cookie Policy of every site you visit.
We have no control over and assume no responsibility for the content, privacy policies or practices of any third party sites or services.
Our Service does not address anyone under the age of 18 (“Children”).
We do not knowingly collect personally identifiable information from anyone under the age of 18. If you are a parent or guardian and you are aware that your Child has provided us with Personal Data, please contact us. If we become aware that we have collected Personal Data from children without verification of parental consent, we take steps to remove that information from our servers.
We may update our Privacy and Cookie Policy from time to time. We will notify you of any changes by posting the new Privacy and Cookie Policy on this page.
We will let you know via email and/or a prominent notice on our Service, prior to the change becoming effective and update the “effective date” at the top of this Privacy and Cookie Policy.
You are advised to review this Privacy and Cookie Policy periodically for any changes. Changes to this Privacy and Cookie Policy are effective when they are posted on this page.
If you have any questions about this Privacy and Cookie Policy, send an email to info@renalsense.com.
Yishai Klein is the Managing Partner and Co-Founder of Singapore-based venture firm, BlueRed Partners. Prior to forming BlueRed, he served as both Advisor and Head of Innovation and Strategic Investments at the OUE group. Formerly, Yishai was Head of Asia at Giza Venture Capital. He currently serves on the boards of Cynet, Gauzy, DouxMatok, Optibus, Panorays and EarlySense.
Avi Kleiman, co-founder of RenalSense, is an experienced entrepreneur with extensive management, marketing and operations experience, 15 years of which have been in the renal and critical care space. As past CEO of MedDynamix, he transformed the company from a young start-up to a global medical device provider. Avi also founded Csoft International, a US software company acquired by Marconi Systems in 1999.
Milton Yisrael is Principal of a Family Office overseeing investments in the US and Israel in a variety of sectors including venture capital, capital markets & real estate. Founder and partner of Hadas Arazim Investment house (today part of Halman Aldubi Investment House), he currently serves as a Board Member, as well as in several other private companies. Milton holds an LLB degree from Bar Ilan University & is a member of the Israeli Bar since 1995.
Cuong Do leads the Global Strategy Group of Samsung’s diverse business portfolio. Previously, he was the Chief Strategy Officer for Merck, Tyco Electronics, and Lenovo. He was also a former senior partner at McKinsey & Company, where he spent 17 years and helped build the healthcare, high tech and corporate finance practices. Cuong holds an MBA from the Tuck School of Business at Dartmouth College.
Hagar Azran manages the company’s clinical trials in Israel and Europe. She has 17 years of experience in clinical research, 10 of which have been in renal disease. Hagar began her clinical career in the In-vitro Fertilization (IVF) Department at Hadassah Hospital in Jerusalem. She then continued her clinical research in the Ophthalmology surgical division at Kaplan Hospital. Hagar received her Bachelor’s degree in life sciences and her Master’s in endocrinology from the Hebrew University in Jerusalem
Aliza Goldman manages the company’s clinical trials in Israel and the US. Formerly a pediatric oncology nurse, she is a published clinical researcher with 10 years of focus on AKI. Aliza received her Bachelor’s in biology from Yeshiva Univ in NY, and her degree in nursing and Master’s in biotechnology from The Hebrew University in Jerusalem. She is also a Registered Nurse in the State of New York and is currently pursuing a PhD in bioethics at Bar-Ilan University in Israel.
Yosh Mantinband is a senior technology executive with extensive experience in all aspects of product design and lifecycle encompassing both hardware and software. Previously, he served in executive management positions at Microsoft, Kayote Networks, and Accent Software International Ltd. (NASDAQ: ACNTF). Yosh holds an MSc in Industrial Engineering and Ergonomics from North Carolina State University and a BSc in EECS from Northwestern University.
Yohanan Engelhardt joined RenalSense in 2015. Prior to joining RenalSense, he served for 18 years as CFO and VP Finance of ViryaNet, a global provider of mobile workforce management software solutions. During his tenure at ViryaNet he played a key role in building the accounting and finance functions, managing the integration of acquisitions, and supporting the company’s IPO and successful sale of the company in 2014 to a large private equity. Yohanan is a Certified Public Accountant in both the US and Israel.
Moti Barda has a wealth of experience in operations management in the electronics & medical device industry. In his previous positions as VP Operations at Mobileye (NYSE:MBLY) and MedDynamix, he established mass production infrastructure logistics in Israel and the Far East, managed supply chains, in- and outsourcing, QA, MRP/ERP development and implementation, and many other key functions. Moti holds an MBA and a BA in electrical engineering and electronics.
Joseph Kochba has vast and diverse experience developing and commercializing medical equipment and multidisciplinary systems. Previously, he served as VP R&D of SuperDimension, a company that introduced a unique lung navigation system for pulmonary cancer care, and as VP R&D for Pythagoras Solar, a company that developed unique building integrated photovoltaic windows. Joseph has also held several leading management roles at Orbotech.
Dr. Mor Grinstein, co-founder of RenalSense, is a published biochemist and experienced scientific and clinical researcher with 10 years of focus on AKI. He received his MSc from Hebrew University and the Max Planck Institute, and his PhD in Medicine from the Technion – Israel Institute of Technology, specializing in renal stem cells. Mor is currently a researcher at Harvard Medical School and Massachusetts General Hospital in Boston.
Adam Goldberger is an experienced business leader having held executive and CFO positions across the technology, health and professional services sectors. Most recently, he was a Group Executive for MedHealth, a leading private equity-backed Australian health risk management platform company which grew from $30m to over $300m utilizing a multi-brand, multi-channel approach to market. Adam has led entrepreneurial companies through significant growth phases and driven change management agendas through innovation and adoption of best practice.
Giora Fishman is a seasoned business executive, with diverse experience in Business Development, Operations, and Sales. Prior to joining RenalSense he held senior management positions, primarily in the Healthcare Industry in the US and in Israel, with companies such as Baxter International, Bristol Myers Squibb, Datascope, and Mennen Medical. Giora holds a B.Sc. in Mechanical Engineering from the Technion in Haifa, Israel
Michael Boxman has 15 years’ experience in medical device sales and business development in the EU and has a deep understanding of the healthcare sector in the different European countries. In his previous position as director of business development EMEA at Eight Medical International, he managed multiple business partners, increased the company’s footprint in new countries and initiated the development of a new patented medical technology. Michael holds an MBA from a Dutch business school.
Mr. Strafaci is an experienced sales and marketing executive with extensive knowledge in launching novel capital and value-added consumables in the hospital market. Most recently, he was an early team member and leader at Cogentix Medical, where he headed the endoscopy business unit with double-digit quarterly sales increases. The company was acquired by Laborie Medical Technologies. Mr. Strafaci is a published co-author in the Journal of Molecular Biology and holds a degree in Biological Sciences from Rutgers University in New Jersey.
Professor Khouli is the Chair of the Department of Critical Care Medicine in the Respiratory Institute at the Cleveland Clinic. Previously he was the Chief of the Critical Care Division at Mt. Sinai West and Mount Sinai St. Luke’s Hospitals in New York City, where he founded the Center for Advanced Medical Simulation (CAMS) and was the Chair of Medical Ethics for over 15 years. Prof. Khouli is on the advisory boards & committees of several regional and national organizations and societies.
Mr. Benhamou has over 25 years’ experience in sales management, product management and business development at companies including Siemens Healthineers, GE Healthcare and Intel Digital Health Group. With a deep understanding of international healthcare systems and the technology needs of various medical specialties, he has vast experience defining and implementing sales strategies. Mr. Benhamou holds an MSc in Biomedical Engineering from Aix-Marseille II University, France.
Dr. Grinstein is a published biochemist and experienced scientific and clinical researcher with 10 years of focus on AKI. He received his MSc from Hebrew University and the Max Planck Institute, and his PhD in Medicine from the Technion – Israel Institute of Technology, specializing in renal stem cells. Dr. Grinstein is currently a researcher at Harvard Medical School and Massachusetts General Hospital in Boston.
Mr. Kleiman is an experienced entrepreneur with extensive management, marketing and operations experience, 15 years of which have been in the renal and critical care space. As past CEO of MedDynamix, he transformed the company from a young start-up to a global medical device provider. Mr. Kleiman also founded Csoft International, a US software company acquired by Marconi Systems in 1999.
Mr. HaCohen is a seasoned C-level and investment professional with 25 years’ experience building and managing multi-national, multi-cultural companies. He is the Founder and a Managing Partner of Jerusalem Technology Investments (TASE: JTI), where he heads the Investments Committee and serves on the boards of several IT and Medical Device companies. Prior to founding JTI, Mr. HaCohen was the Founder, CEO and Chairman of ViryaNet (NASDAQ: VRYA).
Professor Safirstein is an internationally renowned nephrologist and 40-year industry veteran. He is Professor of Internal Medicine at Yale University, past Executive Vice Chair of the Dept. of Internal Medicine, University of Arkansas, and Asst. Editor of Kidney International. Dr. Safirstein holds senior positions at several major medical institutions in the US and at the NIH.
Dr. Caine, a board-certified general surgeon, is Director General of Herzog Hospital in Jerusalem. Prior to assuming his present position, he was a senior staff surgeon at the Hadassah University Hospital in Jerusalem; where he continues to practice as an active surgeon. Dr. Caine has served as Surgeon General of the Israeli Air force and was until recently the President of the International Academy of Aviation and Space Medicine.